Related Experiment Videos
[Pathogenesis of post-transplantation osteopathy]
1Medizinischen Klinik, Klinikums Innenstadt der Ludwig-Maximilians-Universität München, Deutschland.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1996
Summary
Posttransplant osteoporosis is a growing concern after organ transplantation, influenced by factors like hospitalization and immunosuppressive drugs. Individual risk assessment is crucial for preventing and treating this condition.
Area of Science:
- Nephrology
- Endocrinology
- Immunology
Background:
- Osteoporosis is a common complication following allogenic organ transplantation.
- Several factors contribute to its development, including hospitalization, immobilization, and immunosuppressive medications.
Purpose of the Study:
- To review the contributing factors and pathogenesis of posttransplant osteoporosis.
- To emphasize the importance of individual risk factor assessment for prevention and treatment.
Main Methods:
- Literature review of factors contributing to posttransplant osteoporosis.
- Analysis of the role of immunosuppressive drugs and underlying conditions.
Main Results:
- Hospitalization, immobilization, and immunosuppressants (glucocorticoids, cyclosporine A) are key contributors.
- Complications of underlying diseases and adverse drug effects (e.g., laxatives, diuretics, heparin) exacerbate osteoporosis risk.
Conclusions:
- Posttransplant osteoporosis is a multifactorial condition requiring careful management.
- Individualized prevention and treatment strategies based on risk factors are essential for patients undergoing organ transplantation.